Objective To establish with improved accuracy the prevalence of disease related prion protein (PrP CJD

Background: Injecting drug use is a key risk factor, for several infections of public health importance, especially hepatitis B (HBV) and hepatitis C (HCV). In England and Wales, where less than 1% of the population are likely to be injecting drug users (IDUs), approximately 38% of laboratory reports of HBV, and 95% of HCV reports are attributed to injecting drug use.

HighlightsWe monitor HPV infection in sexually active young women in England.The prevalence of HPV 16/18 has reduced within 3 years of HPV immunisation.Reductions in HPV 16/18 were greatest at ages with highest immunisation coverage.The data suggest reductions in HPV 16/18 amongst unvaccinated young women and men.

Since October 2015 up to September 2016, HIV diagnoses fell by 32% compared with October 2014–September 2015 among men who have sex with men (MSM) attending selected London sexual health clinics. This coincided with high HIV testing volumes and rapid initiation of treatment on diagnosis. The fall was most apparent in new HIV testers. Intensified testing of high-risk populations, combined with immediately received anti-retroviral therapy and a pre-exposure prophylaxis (PrEP) programme, may make elimination of HIV achievable.

National Institute for Health Research.